Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nanologica | NICA | Nov 22, 2024 | 1.82 | +5.51 |
NASDAQ OMX Small Cap Sweden GI | NOMXSCSEGI | Nov 22, 2024 | 4 273.81 | +1.38 |
NASDAQ OMX Small Cap Sweden PI | NOMXSCSE | Nov 22, 2024 | 2 635.86 | +1.38 |
Nattaro Labs | NATTA | Nov 22, 2024 | 0.34 | -12.82 |
Navigo Invest AB | NAVIGOSTAM | Nov 22, 2024 | 2.43 | +2.53 |
Navigo Invest Pref | NAVIGOPREF | Nov 22, 2024 | 100.50 | 0.00 |
NAXS | NAXS | Nov 22, 2024 | 51.20 | -0.39 |
NCAB Group | NCAB | Nov 22, 2024 | 56.75 | 0.00 |
NCC A | NCCA | Nov 22, 2024 | 161.50 | +1.25 |
NCC B | NCCB | Nov 22, 2024 | 160.40 | +1.65 |
Nederman Holding | NMAN | Nov 22, 2024 | 219.50 | +0.23 |
NEL | NELO | Nov 22, 2024 | 3.00 | +1.97 |
Nelly Group | NELLY | Nov 22, 2024 | 28.55 | +3.63 |
Neobo Fastigheter | NEOBO | Nov 22, 2024 | 20.49 | +1.19 |
Neola Medical | NEOLA | Nov 22, 2024 | 2.90 | +6.62 |
Neovici Holding B | NEOB | Nov 22, 2024 | 9.50 | +3.83 |
Nepa | NEPA | Nov 22, 2024 | 19.60 | +2.89 |
Net Insight B | NETIB | Nov 22, 2024 | 6.76 | -0.15 |
Netel | NETEL | Nov 22, 2024 | 13.34 | -1.19 |
NetJobs Group | NJOB | Nov 22, 2024 | 0.33 | 0.00 |
New Nordic Healthbrands | NNH | Nov 22, 2024 | 15.00 | 0.00 |
New Wave B | NEWAB | Nov 22, 2024 | 96.60 | +1.10 |
Newbury Pharmaceuticals | NEWBRY | Nov 22, 2024 | 3.32 | -5.68 |
Newlist | NEWL | Nov 22, 2024 | 0.09 | -3.16 |
Nexam Chemical Holding | NEXAM | Nov 22, 2024 | 4.19 | +2.70 |
Nexar Group | NXAR | Nov 22, 2024 | 0.22 | -18.25 |
NextCell Pharma AB | NXTCL | Nov 22, 2024 | 1.73 | -1.70 |
NFO Drives | NFO | Nov 22, 2024 | 34.40 | +0.58 |
Ngenic | NGENIC | Nov 22, 2024 | 1.70 | +0.30 |
NGS Group | NGS | Nov 22, 2024 | 3.12 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.